Clinical Trials Logo

Clinical Trial Summary

The aim of the investigators' study is to evaluate the mucosa-elevating capacity and clinical safety of Sodium Alginate (SA) mixed with Calcium Lactate in assisting Endoscopic Submucosal Dissection/Endoscopic Mucosal Resection.


Clinical Trial Description

The study will evaluate the mucosa-elevating capacity and clinical safety of Gut Guarding Gel (the Sodium Alginate (SA) mixed with Calcium Lactate) in assisting Endoscopic Submucosal Dissection/Endoscopic Mucosal Resection to treat early gastroenterological tumor and polyps.

All participants in the study received Endoscopic submucosal dissection with Sodium Alginate mixed with Calcium Lactate prior to endoscopic resection.

The product is used in Endoscopic submucosal dissection which is accomplished by steps listed as follows: lesion marking, submucosal injection, mucosal incision, submucosal dissection, then en-bloc resection. It's a new submucosal injection regimen, sodium alginate mixed with calcium lactate, which turned to calcium-alginate gel, we called it as "Gut Guarding Gel".

Determine the rates of the delayed bleeding/perforation, postpolypectomy electrocoagulation syndrome, and the late tissue injury. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03321396
Study type Interventional
Source National Cheng-Kung University Hospital
Contact
Status Completed
Phase N/A
Start date September 1, 2017
Completion date August 20, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT06340620 - EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope N/A
Recruiting NCT05394129 - Diagnostic Accuracy of SurePathâ„¢ in EUS-FNA